nppa order (sl.no. 190 to 311) · 2020. 6. 17. · intimated to the nppa in the form-v of dpco,...
TRANSCRIPT
NPPA ORDER (Sl.No. 190 to 311) Shakun Sl.No.190 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
Name of the Formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP*(inclusive of all
taxes)(Rs.) (1) (2) (3) (4) (5) (6)
Each gelatin coated tablet contains
1 Pheniramine Maleate tablets
Pheniramine Maleate-25mg
15’s Al_St 6.64 7.10
2 Pheniramine Maleate tablets
Pheniramine Maleate-25mg
15’s Al_Bl 6.24 6.67
3 Pheniramine Maleate tablets
Pheniramine Maleate-50mg
15’s Al_St 7.44 7.96
4 Pheniramine Maleate tablets
Pheniramine Maleate-50mg
15’s Al_Bl 7.04 7.53
*Subject to actual payment of Government levies/taxes, as applicable. NOTE : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
…/2
Shakun Sl.No.190 & 191 -2- (j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1879(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.191 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2330(E), dated 1st October, 2008, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
Name of the Formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP*(inclusive of
all taxes)(Rs.) (1) (2) (3) (4) (5) (6)
Each coated tablet contains
1 Metronidazole Tablets
Metronidazole - 200 mg 10’s Strip/Blister
3.60 3.85
*Subject to actual payment of Government levies/taxes, as applicable. NOTE : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. …/3
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.191 & 192 -3- Shakun & Company (Services) Pvt. Ltd. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
National Pharmaceutical Pricing Authority S.O.1880(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.192 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 307(E), dated 23rd January, 2009, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
Name of the Formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP*(inclusive of all
taxes)(Rs.) (1) (2) (3) (4) (5) (6)
Each tablet contains 1 Sulphadoxine+
Pyrimethamine Tablets Sulphadoxine - 500 mg Pyrimethamine - 25 mg
2’s Strip/ Blister
3.52 3.76
2 Sulphadoxine+ Pyrimethamine Tablets
Sulphadoxine - 750 mg Pyrimethamine - 37.5 mg
2’s Strip/ Blister
4.88 5.22
*Subject to actual payment of Government levies/taxes, as applicable. NOTE : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. …/4
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.192 & 193 -4- (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
National Pharmaceutical Pricing Authority S.O.1881(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.193 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 170(E), dated 7th February, 2006 and S.O. 437(E), dated 23rd March, 2007, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
Name of the Formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP*(inclusive of
all taxes)(Rs.) (1) (2) (3) (4) (5) (6)
Each dispersible tablet contains
1 Prednisolone Tablets
Prednisolone - 2.5 mg 10’s Strip/Blister
2.72 2.91
…/5
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.193 -5- Shakun & Company (Services) Pvt. Ltd.
(1) (2) (3) (4) (5) (6) Each tablet contains 2 Prednisolone
Tablets Prednisolone - 5 mg 10’s
Strip/Blister 3.44 3.68
3 Prednisolone Tablets
Prednisolone - 10 mg 10’s Strip/Blister
6.04 6.46
4 Prednisolone Tablets
Prednisolone - 20 mg 10’s Strip/Blister
11.16 11.94
5 Prednisolone Tablets
Prednisolone - 30 mg 10’s Strip/Blister
16.26 17.39
6 Prednisolone Tablets
Prednisolone - 40 mg 10’s Strip/Blister
21.26 22.74
*Subject to actual payment of Government levies/taxes, as applicable. NOTE : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
National Pharmaceutical Pricing Authority S.O.1882(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II
…/6
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.194 -6- Shakun & Company (Services) Pvt. Ltd. Shakun Sl.No.194 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
Name of the Formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP*(inclusive of
all taxes)(Rs.) (1) (2) (3) (4) (5) (6)
Each dispersible tablet contains
1 Prednisolone Tablets Prednisolone - 5 mg 10’s Strip/Blister 3.86 4.13 2 Prednisolone Tablets Prednisolone - 10 mg 10’s Strip/Blister 6.48 6.93 3 Prednisolone Tablets Prednisolone - 20 mg 10’s Strip/Blister 11.96 12.79 4 Prednisolone Tablets Prednisolone - 30 mg 10’s Strip/Blister 17.24 18.44 5 Prednisolone Tablets Prednisolone - 40 mg 10’s Strip/Blister 22.36 23.92
*Subject to actual payment of Government levies/taxes, as applicable. NOTE : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
…/7
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.194 & 195 -7- Shakun & Company (Services) Pvt. Ltd. (j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
National Pharmaceutical Pricing Authority S.O.1883(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.195 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1356(E), dated 16th September, 2005, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No.
Name of the Formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP*(inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each Kit contains 1 Rifampicin +
Isoniazide+ Ethambutol Tablets
One film coated tablet of Rifampicin 450mg+ Isoniazide 300mg One uncoated tablet of Ethambutol - 800mg
2’s kit Al-PVC/PVD
C
7.30 7.81
Each fixed/dose combi pack contains
2 Rifampicin+ Isoniazide + Pyrazinamide+ Ethambutol in a fixed dose/ combipack
1 film coated tablet of Rifampicin 600mg Isoniazide 300mg 2 Tablet of Pyrazinamide - 800mg 1 tablet of Ethambutol HCl - 1100mg
10x4’s kit AL-
PVC/PVDC
125.16 133.87
*Subject to actual payment of Government levies/taxes, as applicable. NOTE : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/8
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.195 & 196 -8- Shakun & Company (Services) Pvt. Ltd. (e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
National Pharmaceutical Pricing Authority S.O.1884(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.196 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each hard geltatin capsule contains
“1. Aspirin+ Aspirin - 150 mg 10’s 40.28 43.08” Atorvastatin+ (as enteric coated tablet) Strip/Blister Clopdogrel Atorvastatin calcium eq. to Capsules Atorvastatin - 10 mg Clopdogrel bisulfate eq. to Clopidogrel - 75 mg
*Subject to actual payment of Government levies/taxes, as applicable.
…/9
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.196 & 197 -9- Shakun & Company (Services) Pvt. Ltd. Note : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1885(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.197 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs
(Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of
India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the
prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in
column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of
the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and
pack size specified respectively in the corresponding entries in columns (3) and (4) thereof: …/10
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.197 -10- Shakun & Company (Services) Pvt. Ltd.
Table
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all taxes)
(Rs.) (1) (2) (3) (4) (5) (6)
Each soft gelatin Capsule contains
“1. Multivitamin Lycopene-6% w/w-4000mcg 10’s 6.90 7.38” Capsules Methylcobalamin - 500 mcg Strip/ Natural Vitamin E - 25 IU Blister Selenomethionine - 50 mcg Zinc Ascorbate - 50 mg L-Arginine – 50mg.
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1886(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II
…/11
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.198 -11- Shakun & Company (Services) Pvt. Ltd. Shakun Sl.No.198 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each Film coated tab. contains
“1. Erythromycin+ Erythromycin Stearate eq. to 10’s 24.26 25.95” Bromhexine Erythromycin base - 500 mg Strip/ Tablets Bromhexine HCL - 4 mg Blister
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
…/12
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.198 & 199 -12- Shakun & Company (Services) Pvt. Ltd. (j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1887(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.199 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each Capsule contains:
“1. Multivitamin Dried Ferrous Sulphate-150mg 30’s 18.22 19.49” Capsules Ferrous Fumarate - 75 mg Glass Zinc Sulphate 15 mg Bottle Copper sulphate - 0.8 mg Vitamin B6 - 1.5 mg Vitamin B12 - 6.25 mcg Folic Acid - 1 mg Vitamin C - 75 mg L-histidine hcl H20 - 4 mg L-Lysine hydrochloride - 25 mg Glycine 10 mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/13
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.199 & 200 -13- Shakun & Company (Services) Pvt. Ltd. (e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1888(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.200 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each film coated tablet contains
“1. Pseudoephedrine+ Pseudoephedrine 10’s 7.34 7.85” Levocitrizine Hydrochloride - 120 mg Strip/ Tablets (as extended release granules) Blister Levocitrizine Dihydrochloride - 5.0
mg
*Subject to actual payment of Government levies/taxes, as applicable.
…/14
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.200 & 201 -14- Shakun & Company (Services) Pvt. Ltd. Note : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1889(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.201 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1330(E), dated 15th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/15
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.201 -15- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains
“1. Tolnaftate Tolnaftate - 10mg 20 ml 10.68 11.42” Lotion/Solution Plastic Bottle with Carton
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 8.02 8.58 15 9.34 9.99 20 10.68 11.42 25 12.02 12.86 30 13.36 14.29 50 20.46 21.88 100 35.86 38.36 150 52.04 55.66 200 65.72 70.29 250 79.70 85.25 500 151.22 161.74
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.26732 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/16
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.201 & 202 -16- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1890(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.202 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 320(E), dated 23rd January, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each 5ml Contains
“1. Sulphadoxine + Sulphadoxine - 250 mg 10ml Glass 7.92 8.47” Pyrimethamine Pyrimethamine - 12.5 mg Bottle with Suspension M. Cup & Carton
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.17786 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/17
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 7.92 8.47 20 9.82 10.50 30 11.78 12.60 50 15.84 16.94 100 26.04 27.85 150 37.50 40.11 200 46.86 50.12 250 56.36 60.28 500 106.18 113.57
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.202 & 203 -17- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1891(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.203 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 437(E), dated 23rd March, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/18
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.203 -18- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each 5ml Contains
“1. Prednisolone Prednisolone Sodium 60ml Amber 35.60 38.08” Suspension Phosphate eq to Bottle with Prednisolone 15mg M. Cup & Carton
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.46053 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/19
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 10.74 11.49 20 15.48 16.56 30 20.26 21.67 50 29.98 32.07 100 54.30 58.08 150 79.90 85.46 200 103.40 110.60 250 127.06 135.86 500 247.52 264.75
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.203 & 204 -19- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1892(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.204 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 437(E), dated 23rd March, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each 5ml Contains
“1. Prednisolone Prednisolone Sodium 60ml Amber 34.40 36.79” Suspension Phosphate eq to Bottle with Prednisolone 15mg M. Cup
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
…/20
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 9.85 10.54 20 14.57 15.58 30 19.36 20.71 50 28.77 30.77 100 52.81 56.49 150 77.40 82.79 200 100.89 107.91 250 124.53 133.20 500 243.71 260.67
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.204 & 205 -20- Shakun & Company (Services) Pvt. Ltd.
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.46053 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1893(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.205 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/21
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.205 -21- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains:
“1. Betamethasone+ Betamethasone Dipropionate 15 gm 8.48 9.07” Neomycin Sulphate + eq. to Betamethasone- Plastic Zinc Sulphate 0.05%w/w Tube Cream/Ointments Neomycin Sulphate-0.5% w/w Zinc Sulphate - 0.5% w/w Chlorocresol - 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.06 5.41 10 6.86 7.34 15 8.48 9.07 20 10.22 10.93 25 12.04 12.88 30 13.80 14.76 35 15.78 16.88 50 21.72 23.23
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.27565 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. …/22
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.205 & 206 -22- Shakun & Company (Services) Pvt. Ltd. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1894(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.206 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains:
“1. Betamethasone+ Betamethasone Valerate-0.5 mg 10 gm 7.98 8.54” Neomycin Sulphate + Neomycin Sulphate-5 mg Tube Tolnaftate + Tolnaftate - 10 mg Iodochlorhydro- Iodochlorhydroxyquinoline - 10 mg Xyquinoline Cream/Ointments
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.64 6.03 10 7.98 8.54 15 10.18 10.89 20 12.48 13.35
…/23
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.206 -23- Shakun & Company (Services) Pvt. Ltd.
Column (1) Column (2) Column (3) 25 14.85 15.89 30 17.18 18.38 35 19.74 21.11 50 27.36 29.26
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.38832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1895(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II
…/24
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.207 -24- Shakun & Company (Services) Pvt. Ltd. Shakun Sl.No.207 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains:
“1. Gentamicin+ Gentamicin Sulphate eq. to 7gm 6.68 7.14” Beclomethasone + Gentamicin - 0.10% w/w Tube Tolnaftate + Beclomethasone Clotrimazole + Dipropionate - 0.025% w/w Methyl Paraben+ Clotrimazole - 1.0% w/w Propyl Paraben Tolnaftate - 1.0% w/w Cream/Ointments Methyl Paraben - 0.15% w/w Propyl Paraben - 0.08% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.54 5.93 10 7.80 8.34 15 9.90 10.59 20 12.10 12.94 25 14.38 15.38 30 16.62 17.78 35 19.08 20.41 50 26.44 28.28
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.36975 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. …/25
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.207 & 208 -25- Shakun & Company (Services) Pvt. Ltd. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1896(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.208 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains:
“1. Gentamicin + Gentamicin (as 15gm 9.84 10.52” Clobetaosone + Sulphate)-0.1%w/w Tube Clotrimazole + Clobetaosone Butyrate -0.05% w/w Idochlorhydro- Clotrimazole - 1% w/w xyquinoline+ Idochlorhydroxyquinoline - 1% w/w Zinc Sulphate Zinc Sulphate - 2.5% w/w Cream/Ointments
…/26
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.208 -26- Shakun & Company (Services) Pvt. Ltd. *Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.52 5.90 10 7.76 8.31 15 9.84 10.52 20 12.04 12.88 25 14.30 15.30 30 16.52 17.67 35 18.96 20.28 50 26.26 28.09
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.36632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
…/27
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.208 & 209 -27 Shakun & Company (Services) Pvt. Ltd. (l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1897(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.209 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains:
“1. Gentamycin + Gentamycin Sulphate 10gm 7.30 7.81” Fluocinolone eq. to Gentamicin - 0.1% w/w Tube Acetonide + Fluocinolone Acetonide - 0.01% w/w Ketoconazole + Ketoconazole - 2.0% w/w Zinc Sulphate Zinc Sulphate - 2.50% w/w Cream/Ointments
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.30 5.67 10 7.30 7.81 15 9.16 9.78 20 11.12 11.89 25 13.16 14.08 30 15.14 16.19 35 17.36 18.56 50 23.96 25.63
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.32032 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
…/28
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.209 & 210 -28- Shakun & Company (Services) Pvt. Ltd. (c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ orms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(18) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1898(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.210 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains: “1. Vitamin E Vitamin E Acetate – 1.0% w/w 50gm 17.14 18.33” Acetate+ Sodium Pyrrolidone Plastic Sodium Carboxylic Acid Container/ Pyrrolidone Solution eq. to Sodium Pyrrolidone Tube
…/29
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.210 -29- Shakun & Company (Services) Pvt. Ltd.
(1) (2) (3) (4) (5) (6) Carboxylic Carboxylic Acid - 2.5% w/w Acid + Sodium Lactate Solution eq. to Sodium Sodium Lactate - 2.5% w/w Lactate+ Olive Oil - 3.0% w/w Olive Oil (in aloe vera perfume cream base q.s.) Cream/ As Preservative : Ointments Sodium Methyl Paraben - 0.2% w/w Sodium Propyl Paraben - 0.1% w/w Bronopol - 0.02% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 4.60 4.72 10 5.94 6.35 15 7.10 7.59 20 8.40 8.98 25 9.74 10.42 30 11.04 11.81 35 12.58 13.46 50 17.14 18.33
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.18392 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/30
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.210 & 211 -30- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1899(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.211 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethaosne + Betamethaosne 20gm 11.62 12.43” Salicylic Acid Valerate - 0.061% w/w Tube Cream/Ointments Salicylic Acid - 3.0% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.42 5.80 10 7.56 8.09 15 9.53 10.19 20 11.62 12.43 25 13.78 14.74 30 15.90 17.01 35 18.22 19.49 50 25.22 26.98
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.34532 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/31
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.211 & 212 -31- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1900(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.212 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs
(Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of
India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the
prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in
column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of
the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and
pack size specified respectively in the corresponding entries in columns (3) and (4) thereof: …/32
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.212 -32- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Erythromycin + Erythromycin 3% w/w 15gm 8.44 9.03” Zinc Sulphate Zinc Sulphate 2.5% w/w Tube Cream/Ointments
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.06 5.41 10 6.82 7.29 15 8.44 9.03 20 10.18 10.89 25 11.96 12.79 30 13.72 14.67 35 15.70 16.79 50 21.60 23.10
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.27299 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/33
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.212 & 213 -33- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1901(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.213 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone + Betamethasone Dipropionate 20gm 10.08 10.78” Gentamycin eq. to Betamethasone-0.05%w/w Tube Cream/Ointments Gentamycin Sulphate eq. to Gentamycin base - 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.04 5.39 10 6.78 7.25 15 8.38 8.96 20 10.08 10.78 25 11.86 12.69 30 13.58 14.53 35 15.54 16.62 50 21.36 22.85
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.26832 per gm. from the
ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/34
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.213 & 214 -34- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1902(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.214 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/35
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.214 -35- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone + Betamethasone Dipropionate 25gm 11.78 12.60” Salicylic Acid eq. to Betamethasone-0.05%w/w Tube Cream/Ointments Salicylic Acid - 3.0% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.02 5.37 10 6.76 7.23 15 8.32 8.90 20 10.02 10.72 25 11.78 12.60 30 13.50 14.44 35 15.44 16.51 50 21.22 22.70
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.26552 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/36
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.214 & 215 -36- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1903(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.215 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Methylprednisolone+ Methylprednisolone 10gm 7.38 7.89” Benzyl Alcohol Aceponate - 0.1% w/w Tube Cream/Ointments Benzyl Alcohol - 1.0% w/w
(as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.34 5.71 10 7.38 7.89 15 9.28 9.93 20 11.28 12.07 25 13.36 14.28 30 15.38 16.45 35 17.64 18.87 50 24.36 26.06
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.32832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/37
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.215 & 216 -37- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1904(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.216 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs
(Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of
India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the
prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in
column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of
the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and
pack size specified respectively in the corresponding entries in columns (3) and (4) thereof: …/38
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.216 -38- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Gentamycin Gentamycin Sulphate eq. to 10gm 5.58 5.97” Cream/Ointments Gentamycin base - 0.1 % w/w Tube
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 4.44 4.75 10 5.58 5.97 15 6.58 7.04 20 7.68 8.21 25 8.86 9.48 30 9.98 10.67 35 11.34 12.13 50 15.36 16.43
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.14832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/39
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.216 & 217 -39- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1905(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.217 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml Contains “1. Betamethasone+ Betamethasone Dipropionate 17ml 9.30 9.95” Clotrimazole eq. to Betamethasone-0.05%w/v Plastic Lotion/Solution Clotrimazole - 1.00% w/v Container
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 6.79 7.26 20 10.09 10.79 30 13.60 14.55 50 21.39 22.88 100 41.34 44.22 150 60.77 65.00 200 80.54 86.15 250 99.99 106.94 500 197.61 211.36
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.26891 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/40
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.217 & 218 -40- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1906(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.218 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/41
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.218 -41- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml Contains “1. Betamethasone+ Betamethasone Dipropionate 50ml 21.04 22.50” Zinc Sulphate+ eq. to Betamethasone-0.05%w/v Tube Methylparaben+ Zinc Sulphate - 0.5%w/v Propylparaben Methylparaben - 0.18% w/v Lotion/Solution Propylparaben - 0.02% w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 6.72 7.19 20 9.95 10.64 30 13.39 14.32 50 21.04 22.50 100 40.64 43.47 150 59.72 63.88 200 79.14 84.65 250 98.24 105.08 500 194.12 207.63
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.26192 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/42
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.218 & 219 -42- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1907(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.219 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Dexamethasone + Dexamethaosne Sodium 10ml 9.22 9.86” Ofloxacin+ Phosphate - 0.01% w/v Vial Hydroxy Propyl Ofloxacin - 0.3% w/v with Methyl Cellulose+ Hydroxy Propyl Methyl Dropper Benzalkonium Cellulose - 0.025% w/v & Chloride Eye/Ear Benzalkonium Chloride Carton Drops Solution - 0.02% v/v (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 8.20 8.77 10 9.22 9.86 15 10.02 10.72 20 11.00 11.77 30 11.60 12.41 50 14.24 15.23 100 20.24 21.65
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.06000 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/43
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.219 & 220 -43- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1908(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.220 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs
(Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of
India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the
prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in
column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of
the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and
pack size specified respectively in the corresponding entries in columns (3) and (4) thereof: …/44
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.220 -44- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Dexamethasone + Dexamethasone Sodium 10ml Vial 10.34 11.06” Phenyl Mercuric Phosphate - 0.1 w/v with Dropper Nitrate Eye/Ear Phenyl Mercuric & Carton Drops Nitrate - 0.001% w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 8.26 8.83 10 10.34 11.06 15 11.70 12.51 20 13.68 14.63 30 16.00 17.11 50 21.52 23.02 100 34.92 37.35
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.15200 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/45
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.220 & 221 -45- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1909(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.221 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each 5ml Contains “1. Metronidazole + Metronidazole Benzoate 30ml Bottle 10.20 10.91” Norfloxacin eq. to Metronidazole-120mg Suspension Norfloxacin-125mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.15519 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/46
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
10 6.80 7.27 20 8.46 9.05 30 10.20 10.91 50 13.50 14.44 100 22.28 23.83 150 31.60 33.80 200 39.82 42.59 250 48.20 51.55 500 91.04 97.38
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.221 & 222 -46- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1910(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.222 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/47
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.222 -47- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each 0.6 ml contains “1. Multivitamin Vit. A (added as vitamin 15ml Bottle 10.22 10.93” Drops A concentrate oily form with Dropper as Palmitate) - 5000 IU & Carton Cholecalciferol - 400 IU Thiamine HCL - 1.5 mg Riboflavin (as riboflavin-5-
phosphate Sodium) - 1.2 mg
Nicotinamide - 10 mg Pyridoxin HCL - 1 mg Ascorbic Acid - 50 mg Zinc Sulphate - 1.05 mg Ferrous Gluconate - 2 mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 7.36 7.87 10 8.74 9.35 15 10.22 10.93 20 11.60 12.41 30 14.52 15.53 50 20.50 21.93 100 35.52 37.99
For pack size other than pack size given in column (1) of the table – II deduct @ Rs. 0.27392 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. …/48
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.222 & 223 -48- Shakun & Company (Services) Pvt. Ltd. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1911(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.223 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 765(E), dated 28th March, 2008, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each tablet contains “1. Betamethasone
Tablet Betamethasone - 0.5mg (as Sodium Phosphate)
10’s Al_St 3.12 3.34
2. Betamethasone
Tablet Betamethasone - 0.5mg (as Sodium Phosphate)
10’s Al_Bl 2.90 3.10
3. Betamethasone
Tablet Betamethasone - 1mg (as Sodium Phosphate)
10’s Al_St 5.10 5.45
4. Betamethasone
Tablet Betamethasone - 1mg (as Sodium Phosphate)
10’s Al_Bl 4.84 5.18
5. Betamethasone
Tablet Betamethasone - 0.5mg (as Betamethasone Alcohol)
10’s Al_St 3.06 3.27
6. Betamethasone
Tablet Betamethasone - 0.5mg (as Betamethasone Alcohol)
10’s Al_Bl 2.84 3.04”
*Subject to actual payment of Government levies/taxes, as applicable.
…/49
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.223 & 224 -49- Shakun & Company (Services) Pvt. Ltd. Note : (a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for
the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet and capsule packed in strip/blister. (d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (h) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(i) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(j) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(k) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand automatically withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1912(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.224 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/50
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.224 -50- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 15 gm 8.34 8.92” Gentamycin Dripropionate 0.064%w/w Tube Cream/Ointment eq. to 0.05% w/w of Betamethasone Gentamycin Sulphate - 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.02 5.37 10 6.76 7.23 15 8.34 8.92 20 10.04 10.73 25 11.80 12.62 30 13.52 14.46 35 15.46 16.54 50 21.26 22.74
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/51
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.224 & 225 -51- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1913(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.225 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 10.20 10.91 Neomycin+ Valerate - 0.12% w/w Laqured Miconazole Neomycin Sulphate - 0.5%w/w Tube Cream/Ointment Miconazole Nitrate - 2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 6.89 7.37 10 10.20 10.91 15 13.57 14.51 20 16.78 17.95 25 20.11 21.51 30 23.34 24.96 35 27.15 29.04 50 38.62 41.31
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.58432 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/52
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.225 & 226 -52- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1914(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.226 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/53
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.226 -53- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 9.94 10.63” Neomycin+ Valerate - 0.12% w/w Unlaqured Miconazole Neomycin Sulphate - 0.5%w/w Tube Cream/Ointment Miconazole Nitrate - 2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 6.61 7.07 10 9.94 10.63 15 13.11 14.02 20 16.40 17.54 25 19.75 21.12 30 23.06 24.66 35 26.59 28.44 50 37.16 39.75
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/54
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.226 & 227 -54- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1915(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.227 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 7.08 7.57” Miconazole Dipropionate 0.064% w/w Tube Cream/Ointment eq to 0.05% w/w of Betamethasone Miconazole Nitrate - 2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.18 5.54 10 7.08 7.57 15 8.82 9.43 20 10.68 11.42 25 12.60 13.48 30 14.48 15.49 35 16.58 17.73 50 22.86 24.45
…/55
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.227 & 228 -55- Shakun & Company (Services) Pvt. Ltd.
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.29832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1916(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.228 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/56
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.228 -56- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 6.86 7.34” Salicylic Acid+ Dipropionate 0.064% w/w Tube Urea + eq to 0.05% w/w of Betamethasone Lactic Acid + Salicylic Acid -3% w/w Sodium Lactate Urea - 10% w/w Cream/Ointment Lactic Acid Bacillus -3% w/w Sodium Lactate – 2%w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.07 5.42 10 6.86 7.34 15 8.49 9.08 20 10.24 10.95 25 12.05 12.89 30 13.82 14.78 35 15.81 16.91 50 21.76 23.27
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.27632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/57
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.228 & 229 -57- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1917(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.229 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 6.84 7.32” Neomycin Dipropionate 0.064% w/w Tube Cream/Ointment eq to 0.05% w/w of Betamethasone Neomycin Sulphate- 0.57% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.06 5.41 10 6.84 7.32 15 8.46 9.05 20 10.20 10.91 25 12.00 12.83 30 13.76 14.72 35 15.74 16.84 50 21.66 23.17
…/58
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.229 & 230 -58- Shakun & Company (Services) Pvt. Ltd.
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.27432 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1918(E) PN/110/2009F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.230 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/59
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.230 -59- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 6.92 7.40” Neomycin+ Dipropionate 0.064% w/w Tube Clotrimazole eq to 0.05% w/w of Betamethasone Cream/Ointment Neomycin Sulphate- 0.5% w/w Clotrimazole -1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.10 5.45 10 6.92 7.40 15 8.58 9.18 20 10.36 11.08 25 12.20 13.05 30 14.00 14.97 35 16.02 17.13 50 22.06 23.59
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.28232 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/60
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.230 & 231 -60- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1919(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.231 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 15 gm 8.32 8.90” Neomycin Dipropionate 0.064% w/w Tube Cream/Ointment eq to 0.05% w/w of Betamethasone Neomycin Sulphate- 0.25% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.01 5.36 10 6.75 7.22 15 8.32 8.90 20 10.01 10.71 25 11.77 12.59 30 13.48 14.42 35 15.41 16.48 50 21.19 22.66
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.26499 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/61
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.231 & 232 -61- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1920(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.232 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/62
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.232 -62- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone Betamethasone -0.1% w/w 30 gm 16.90 18.08” Cream/Ointment Tube
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.58 5.97 10 7.89 8.44 15 10.03 10.73 20 12.29 13.15 25 14.62 15.64 30 16.90 18.08 35 19.40 20.75 50 26.89 28.76
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.37899 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
…/63
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.232 & 233 -63- Shakun & Company (Services) Pvt. Ltd. (k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1921(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.233 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone-0.1% w/w 30 gm 18.60 19.89” Clloquinol (ICHQ) Clloquinol (ICHQ) - 3% w/w Tube Cream/Ointment
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.87 6.28 10 8.45 9.04 15 10.88 11.64 20 13.43 14.36 25 16.03 17.15 30 18.60 19.89 35 21.39 22.88 50 29.73 31.80
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.43565 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/64
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.233 & 234 -64- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1922(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.234 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/65
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.234 -65- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone -0.05% w/w 20 gm 10.14 10.85” Salicylic Acid Salicylic Acid 6% w/w Tube Cream/Ointment
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.05 5.40 10 6.81 7.28 15 8.42 9.01 20 10.14 10.85 25 11.93 12.76 30 13.67 14.62 35 15.64 16.73 50 21.51 23.01
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.27132 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/66
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.234 & 235 -66- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1923(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.235 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.04 10.74” Gentamycin Dipropionate -0.064mg Tube Cream/Ointment Gentamycin Sulphate - 1mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.02 5.37 10 6.76 7.23 15 8.34 8.92 20 10.04 10.74 25 11.80 12.62 30 13.52 14.46 35 15.46 16.54 50 21.26 22.74
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
…/67
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.235 & 236 -67- Shakun & Company (Services) Pvt. Ltd. (b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1924(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.236 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/68
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.236 -68- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 15 gm 8.94 9.56” Gentamycin+ Dipropionate -0.064% w/w Tube Miconazole Nitrate Gentamycin 0.1% w/w Cream/Ointment Miconazole Nitrate - 2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.22 5.58 10 7.16 7.66 15 8.94 9.56 20 10.84 11.59 25 12.80 13.69 30 14.72 15.74 35 16.86 18.03 50 23.26 24.88
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.30632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/69
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.236 & 237 -69- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1925(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.237 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 6.92 7.40” Gentamycin+ Dipropionate -0.064% w/w Tube Miconazole eq. to Betamethasone 0.05% w/w Cream/Ointment Gentamycin 0.05% w/w Miconazole Nitrate - 1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.10 5.45 10 6.92 7.40 15 8.58 9.18 20 10.36 11.08 25 12.20 13.05 30 14.00 14.97 35 16.02 17.13 50 22.06 23.60
…/70
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.237 & 238 -70- Shakun & Company (Services) Pvt. Ltd.
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.28232 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1926(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.238 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
…/71
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.238 -71- Shakun & Company (Services) Pvt. Ltd.
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 16 gm 9.16 9.80” Gentamycin + Dipropionate -0.064% w/w Tube Neomycin eq. to Betamethasone 0.05% w/w Cream/Ointment Gentamycin - 0.05% w/w Neomycin Sulphate - 0.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.07 5.42 10 6.87 7.35 15 8.50 9.09 20 10.26 10.97 25 12.07 12.91 30 13.84 14.80 35 15.84 16.94 50 21.80 23.32
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.27707 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
…/72
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.238 & 239 -72- Shakun & Company (Services) Pvt. Ltd. (j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1927(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II Shakun Sl.No.239 -COPY OF- ORDER Dated 3rd August, 2009 In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6) Each gm contains “1. Betamethasone+ Betamethasone 10 gm 7.82 8.36” Gentamycin+ Dipropionate 0.10% w/w Tube Miconazole Nitrate Gentamycin 0.1% w/w Cream/Ointment Miconazole Nitrate - 2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table – II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.) Column (1) Column (2) Column (3)
5 5.55 5.94 10 7.82 8.36 15 9.93 10.62 20 12.16 13.01 25 14.45 15.46 30 16.70 17.86 35 19.17 20.50 50 26.56 28.41
…/73
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.239 -73- Shakun & Company (Services) Pvt. Ltd.
For pack size other than pack size given in column (1) of the table – II deduct @ Rs 0.37232 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table – I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a
factor of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1928(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.II
…/74
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.240 -74- Shakun & Company (Services) Private Limited Shakun Sl.No.240 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+
Gentamycin+ Iodochlorhydroxy- quinoline Cream/ Ointment
Betamethasone Dipropionate 0.1% w/w Gentamycin Base-0.2% w/w Iodochlorhydroxyquinoline-2% w/w
5 gm Tube
5.58 5.97”
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.58 5.97 10 7.88 8.43 15 10.02 10.72 20 12.28 13.13 25 14.60 15.62 30 16.88 18.05 35 19.38 20.73 50 26.86 28.73
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.37832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. …/75
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.240 & 241 -75- Shakun & Company (Services) Private Limited (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1929(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.241 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1363(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.30 11.02” Salicylic Acid + Dipropionate 0.064% w/w Tube Urea + Lactic Acid eq to 0.05% w/w of Betamethasone Sodium Lactate Salicyclic Acid 3%w/w Cream/Ointment Urea - 10% w/w Lactic Acid Bacillus 3% w/w Sodium Lactate 3% w/w
*Subject to actual payment of Government levies/taxes, as applicable. …/76
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.241 -76- Shakun & Company (Services) Private Limited Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.08 5.43 10 6.90 7.38 15 8.54 9.13 20 10.30 11.02 25 12.12 12.96 30 13.92 14.89 35 15.92 17.03 50 21.92 23.45
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27932 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1930(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/77
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.242 -77- Shakun & Company (Services) Private Limited Shakun Sl.No.242 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1363(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.20 10.91” Salicylic Acid + Dipropionate 0.064% w/w Tube Zinc Oxide eq to 0.05% w/w of Betamethasone Cream/Ointment Salicyclic Acid 6.50%w/w Zinc Oxide - 0.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.06 5.41 10 6.84 7.32 15 8.46 9.05 20 10.20 10.91 25 12.00 12.83 30 13.76 14.72 35 15.74 16.84 50 21.66 23.17
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27432 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/78
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.242 & 243 -78- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1931(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.243 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1364(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.38 11.10” Salicylic Acid + Dipropionate 0.064% w/w Tube Lactic Acid+ eq to 0.05% w/w of Betamethasone Sodium Lactate Salicyclic Acid 6%w/w Cream/Ointment Lactic Acid Bacillus 3.00% w/w Sodium Lactate Solution eq to Lactic Acid 2.00% w/w
*Subject to actual payment of Government levies/taxes, as applicable.
…/79
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.243 -79- Shakun & Company (Services) Private Limited Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.11 5.47 10 6.93 7.41 15 8.60 9.20 20 10.38 11.10 25 12.23 13.08 30 14.03 15.01 35 16.06 17.18 50 22.11 23.64
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.28332 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1932(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/80
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.244 -80- Shakun & Company (Services) Private Limited Shakun Sl.No.244 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1365(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 21.78 23.30” Absolute Alcohol Valerate - 0.12%w/w Tube Cream/Ointment Absolute Alcohol - 31.70% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.40 6.85 10 9.51 10.17 15 12.47 13.34 20 15.55 16.63 25 18.68 19.98 30 21.78 23.30 35 25.10 26.85 50 35.03 37.47
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.54165 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/81
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.244 & 245 -81- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1933(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.245 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1368(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 13.56 14.50” Salicyclic Acid+ Dipropionate - 0.064%w/w Tube Zinc Sulphate eq to Betamethasone - 0.05%w/w Cream/Ointment Salicyclic Acid 3.5%w/w Zinc Sulphate 0.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/82
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.245 -82- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.03 5.38 10 6.77 7.24 15 8.36 8.94 20 10.07 10.77 25 11.83 12.65 30 13.56 14.50 35 15.51 16.59 50 21.33 22.81
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26765 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1934(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/83
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.246 -83- Shakun & Company (Services) Private Limited Shakun Sl.No.246 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1367(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 13.64 14.59” Gentamycin + Dipropionate - 0.064%w/w Tube Zinc Sulphate eq to Betamethasone - 0.05%w/w Cream/Ointment Gentamycin Sulphate 0.1%w/w Zinc Sulphate 0.5% w/w Chlorocresol 0.1% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.04 5.39 10 6.80 7.27 15 8.40 8.98 20 10.12 10.82 25 11.90 12.73 30 13.64 14.59 35 15.60 16.69 50 21.46 22.95
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27032 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/84
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.246 & 247 -84- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1935(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.247 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1372(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.26 10.97” Salicyclic Acid + Dipropionate - 0.064%w/w Tube Lactic Acid+ eq to Betamethason - 0.05%w/w Sodium Lactate Salicyclic Acid 3%w/w Cream/Ointment Lactic Acid Bacillus 3.00% w/w Sodium Lactate Solution eq to Lactic Acid 2.00% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/85
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.247 -85- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.08 5.43 10 6.87 7.35 15 8.51 9.10 20 10.26 10.97 25 12.08 12.92 30 13.85 14.81 35 15.85 16.95 50 21.81 23.33
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27732 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1936(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/86
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.248 -86- Shakun & Company (Services) Private Limited Shakun Sl.No.248 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone Valerate -1mg 10gm 21.54 23.04” Fusedic Acid Fusedic Acid-20mg Tube Cream/Ointments
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 12.42 13.28 10 21.54 23.04 15 30.52 32.64 20 39.60 42.36 25 48.76 52.15 30 57.86 61.89 35 67.20 71.88 50 95.16 101.78
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 1.17565 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/87
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.248 & 249 -87- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1937(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.249 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1380(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.16 10.87” Salicyclic Acid + Dipropionate- 0.064% w/w Tube Zinc Oxide eq to Betamethasone - 0.05% w/w Cream/Ointment Salicyclic Acid 6% w/w Zinc Oxide 0.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/88
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.249 -88- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.05 5.40 10 6.82 7.29 15 8.43 9.02 20 10.16 10.87 25 11.95 12.78 30 13.70 14.65 35 15.67 16.76 50 21.56 23.06
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27232 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1938(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/89
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.250 -89- Shakun & Company (Services) Private Limited Shakun Sl.No.250 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1382(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone Betamethasone Dipropionate 18 gm 7.78 8.32” Cream/Ointment eq to Betamethasone - 0.0125%w/w Tube Chlorocresol 0.1% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 4.54 4.86 10 5.80 6.20 15 6.90 7.38 20 8.12 8.69 25 9.41 10.06 30 10.65 11.39 35 12.11 12.95 50 16.47 17.62
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.17054 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/90
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.250 & 251 -90- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1939(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.251 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1383(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 15 gm 8.26 8.83” Zinc Sulphate Dipropionate 0.064% w/w Tube Cream/Ointment eq to Betamethasone - 0.05%w/w Zinc Sulphate 0.5% w/w Chlorocresol 0.1% w/w (as Presevative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/91
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.251 -91- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.00 5.35 10 6.70 7.17 15 8.26 8.83 20 9.94 10.63 25 11.68 12.49 30 13.36 14.29 35 15.28 16.34 50 21.00 22.46
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26099 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1940(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/92
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.252 -92- Shakun & Company (Services) Private Limited Shakun Sl.No.252 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1384(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 15 gm 8.36 8.94” Salicylic Acid+ Dipropionate 0.064% w/w Tube Zinc Oxide eq to Betamethasone - 0.05%w/w Cream/Ointment Salicylic Acid 3.5% w/w Zinc Oxide 0.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.02 5.37 10 6.78 7.25 15 8.36 8.94 20 10.06 10.76 25 11.84 12.66 30 13.56 14.50 35 15.50 16.58 50 21.32 22.80
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/93
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.252 & 253 -93- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1941(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.253 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1336(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 13.60 14.55” Salicyclic Acid+ Dipropionate 0.064% w/w Tube Zinc sulphate eq to Betamethasone - 0.05%w/w Cream/Ointment Salicyclic Acid 3.50%w/w Zinc sulphate 0.5%w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/94
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.253 -94- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.04 5.39 10 6.78 7.25 15 8.38 8.96 20 10.10 10.80 25 11.86 12.68 30 13.60 14.55 35 15.56 16.64 50 21.40 22.89
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26899 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1942(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/95
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.254 -95- Shakun & Company (Services) Private Limited Shakun Sl.No.254 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 755(E), dated 28th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone - 0.1%w/w 30 gm 20.70 22.14” Absolute Alchohol Absolute Alchohol - 76.05%v/w Tube Cream/Ointment
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.22 6.65 10 9.16 9.79 15 11.94 12.77 20 14.82 15.85 25 17.78 19.02 30 20.70 22.14 35 23.84 25.50 50 33.22 35.53
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.50565 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/96
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.254 & 255 -96- Shakun & Company (Services) Private Limited
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1943(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.255 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2047(E), dated 30th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.18 10.89” Salicylic Acid+ Dipropionate- 0.064% w/w Tube Lactic Acid+ Urea eq to Betamethasone 0.05%w/v Cream/Ointment Salicylic Acid -3.0% w/w Lactic Acid - 3.0% w/w Urea - 10.0%w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/97
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.255 -97- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.06 5.41 10 6.84 7.32 15 8.44 9.03 20 10.18 10.89 25 11.98 12.81 30 13.74 14.70 35 15.70 16.79 50 21.62 23.12
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27332 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1944(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/98
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.256 -98- Shakun & Company (Services) Private Limited Shakun Sl.No.256 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2047(E), dated 30th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 10 gm 19.46 20.81” Fusidic Acid Dipropionate- 0.064% w/w Tube Cream/Ointment eq to Betamethasone 0.05%w/v Fusidic Acid - 2.0% w/w Chlorocresol - 0.1%w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 11.38 12.17 10 19.46 20.81 15 27.40 29.31 20 35.44 37.91 25 43.56 46.59 30 51.62 55.21 35 59.92 64.09 50 84.76 90.66
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 1.53632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/99
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.256 & 257 -99- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1945(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.257 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2047(E), dated 30th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 13.52 14.46” Gentamycin Dipropionate- 0.064% w/w Tube Cream/Ointment eq to Betamethasone 0.05%w/v Gentamycin Sulphate eq. to Gentamycin base-0.10% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/100
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.257 -100- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.02 5.37 10 6.76 7.23 15 8.34 8.92 20 10.04 10.74 25 11.80 12.62 30 13.52 14.46 35 15.46 16.54 50 21.26 22.74
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1946(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/101
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.258 -101- Shakun & Company (Services) Private Limited Shakun Sl.No.258 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 755(E), dated 28th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 5 gm 23.92 25.58” Mupirocin Dipropionate- 0.064% w/w Tube Cream/Ointment eq to Betamethasone 0.05%w/v Mupirocin- 2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 23.92 25.58 10 44.56 47.66 15 65.04 69.57 20 85.64 91.60 25 106.30 113.70 30 126.92 98.40 35 147.76 158.04 50 210.26 224.89
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 4.04632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/102
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.258 & 259 -102- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1947(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.259 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1473(E), dated 15th June, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 5 gm 5.38 5.75” Gentamycin+ Dipropionate 0.643mg Tube Tolanftate+ ICHQ Gentamycin Sulphate Cream/Ointment eq to Gentamycin base - 1mg Tolanftate -10mg, ICHQ -10mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/103
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.259 -103- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.38 5.75 10 7.48 8.01 15 9.42 10.08 20 11.48 12.28 25 13.60 14.55 30 15.68 16.77 35 17.98 19.23 50 24.86 26.59
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.33832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1948(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/104
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.260 -104- Shakun & Company (Services) Private Limited Shakun Sl.No.260 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1636(E), dated 27th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 17 gm 9.30 9.95” Gentamycin Dipropionate 0.064% w/w Tube Cream/Ointment eq. to Betamethasone 0.05% w/w Gentamycin 0.10% w/w Chlorocresol 0.10% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.02 5.37 10 6.78 7.25 15 8.38 8.96 20 10.10 10.80 25 11.86 12.69 30 13.60 14.55 35 15.55 16.63 50 21.38 22.87
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26891 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/105
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.260 & 261 -105- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1949(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.261 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1636(E), dated 27th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 10 gm 6.64 7.10” Neomycin+ Dipropionate 0.025% to 0.05%w/w Tube Miconazole Neomycin Sulphate - 0.50% w/w Cream/Ointment Miconazole Nitrate - 2.00% w/w Chlorocresol - 0.1% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/106
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.261 -106- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 4.96 5.31 10 6.64 7.10 15 8.16 8.73 20 9.80 10.48 25 11.50 12.30 30 13.16 14.08 35 15.04 16.09 50 20.66 22.10
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.25432 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1950(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/107
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.262 -107- Shakun & Company (Services) Private Limited Shakun Sl.No.262 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 173(E), dated 29th January, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 7 gm 5.98 6.40” Clotrimazole Dipropionate 0.064% w/w Tube Cream/Ointment eq. to Betamethasone - 0.05%w/w Clotrimazole-1%w/w Chlorocresol - 0.1% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.04 5.39 10 6.80 7.27 15 8.40 8.98 20 10.10 10.80 25 11.88 12.71 30 13.62 14.57 35 15.58 16.66 50 21.42 22.91
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26975 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/108
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.262 & 263 -108- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1951(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.263 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 173(E), dated 29th November, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 8 gm 6.38 6.82” Neomycin + Dipropionate 0.064% w/w Tube Clotrimazole eq. to Betamethasone - 0.05%w/w Cream/Ointment Neomycin Sulphate - 0.50%w/w Clotrimazole-1%w/w Chlorocresol - 0.1% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/109
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.263 -109- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.12 5.48 10 6.96 7.44 15 8.64 9.24 20 10.44 11.17 25 12.28 13.13 30 14.10 15.08 35 16.14 17.26 50 22.24 23.79
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.28582 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1952(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/110
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.264 -110- Shakun & Company (Services) Private Limited Shakun Sl.No.264 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 622(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20 gm 10.32 11.04” Salicylic Acid+ Dipropionate 0.064% 0w/w Tube Lactic Acid +Urea eq. to Betamethasone - 0.05%w/w Cream/Ointment Salicylic Acid -3% w/w Lactic Acid - 5% w/w Urea - 10% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.10 5.45 10 6.90 7.38 15 8.56 9.16 20 10.32 11.04 25 12.16 12.88 30 13.94 14.91 35 15.96 17.07 50 21.96 23.49
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.28032 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/111
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.264 & 265 -111- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1953(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.265 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 623(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 21.60 23.10” Salicylic Acid Valerate -0.12% w/w Tube Cream/Ointment Salicylic Acid -2.0% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/112
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.265 -112- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.36 6.80 10 9.46 10.12 15 12.38 13.24 20 15.42 16.49 25 18.54 19.83 30 21.60 23.10 35 24.88 26.61 50 34.72 37.14
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.53565 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1954(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/113
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.266 -113- Shakun & Company (Services) Private Limited Shakun Sl.No.266 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 624(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30 gm 22.94 24.54” Gentamycin+ Valerate -0.12% w/w Tube Miconazole Nitrate Gentamycin- 0.1% w/w Cream/Ointment Miconazole Nitrate -2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.60 7.06 10 9.90 10.59 15 13.06 13.97 20 16.32 17.46 25 19.66 21.03 30 22.94 24.54 35 26.46 28.30 50 36.96 39.53
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.58032 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/114
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.266 & 267 -114- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1955(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.267 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 626(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone -0.025% w/w 15 gm 7.34 7.85” Cream/Ointment Tube
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/115
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.267 -115- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 4.68 5.01 10 6.10 6.52 15 7.34 7.85 20 8.70 9.31 25 10.14 10.85 30 11.52 12.32 35 13.12 14.03 50 17.92 19.17
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.19965 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1956(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/116
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.268 -116- Shakun & Company (Services) Private Limited Shakun Sl.No.268 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 628(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 10 gm 6.76 7.23” Salicylic Acid+ Dipropionate-0.64mg Tube Cream/Ointment Salicylic Acid - 30 mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.02 5.37 10 6.76 7.23 15 8.34 8.92 20 10.04 10.74 25 11.80 12.62 30 13.52 14.46 35 15.46 16.54 50 21.26 22.74
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/117
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.268 & 269 -117- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1957(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.269 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 630(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 18 gm 9.38 10.03” Cream/Ointment Dipropionate-0.064% w/w Tube Eq. to Betamethasone-0.05% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/118
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.269 -118- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 4.98 5.33 10 6.70 7.17 15 8.24 8.81 20 9.90 10.59 25 11.62 12.43 30 13.32 14.25 35 15.22 16.28 50 20.92 22.38
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.25943 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1958(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/119
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.270 -119- Shakun & Company (Services) Private Limited Shakun Sl.No.270 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 633(E), dated 24th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 18 gm 9.74 10.42” Gentamycin+ Dipropionate-0.064% w/w Tube Clotrimazole Eq. to Betamethasone-0.05% w/w Cream/Ointments Gentamycin Sulphate eq. to Gentamycin Base-0.10%w/w Clotrimazole-1.0%w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.04 5.44 10 6.89 7.37 15 8.54 9.13 20 10.30 11.02 25 12.13 12.96 30 13.91 14.89 35 15.92 17.03 50 21.92 23.45
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.39965 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/120
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.270 & 271 -120- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1959(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.271 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1362(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 15 gm 8.42 9.01” Clotrimazole+ Dipropionate-0.064% w/w Tube Zinc Sulphate Eq. to Betamethasone-0.05% w/w Cream/Ointments Clotrimazole-1.0%w/w Zinc sulphate 0.5%w/w Chlorocresol- 0.1%w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/121
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.271 -121- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.04 5.39 10 6.82 7.29 15 8.42 9.01 20 10.14 10.85 25 11.94 12.77 30 13.68 14.63 35 15.64 16.73 50 21.52 23.02
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.27165 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1960(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/122
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.272 -122- Shakun & Company (Services) Private Limited Shakun Sl.No.272 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1472(E), dated 15th June, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone Valerate-0.61mg 5gm 5.96 6.37” Gentamycin + Gentamycin Sulphate -1mg Tube Tolnaftate+ ICHQ Tolnaftate 15mg Cream/Ointments ICHQ 15mg Chlorocresol- 1mg (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.96 6.37 10 8.64 9.24 15 11.16 11.94 20 13.80 14.76 25 16.50 17.65 30 19.16 20.49 35 22.04 23.57 50 30.66 32.79
For pack size other than pack size given in column (1) of the table- II deduct @ Rs 0.45432 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/123
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.272 & 273 -123- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1961(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.273 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1474(E), dated 15th June, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 5gm 5.28 5.65” Neomycin+ Dipropionate-0.5mg Tube Tolnaftate+ICHQ Neomycin Sulphate 5mg Cream/Ointments Tolnaftate -10mg ICHQ -10mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/124
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.273 -124- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.28 5.65 10 7.28 7.79 15 9.12 9.75 20 11.08 11.85 25 13.10 14.01 30 15.08 16.13 35 17.28 18.48 50 23.86 25.52
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.31832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1962(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/125
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.274 -125- Shakun & Company (Services) Private Limited Shakun Sl.No.274 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1475(E), dated 15th June, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 6gm 6.16 6.59” Neomycin+ Dipropionate 0.064%w/w eq. to Tube Clotrimazole + Betamethasone-0.05% w/w Tolnaftate Neomycin Sulphate- 0.5%w/w Cream/Ointments Clotrimazole-1.0%w/w Tolnaftate- 1.0%w/w Chlorocresol- 0.1%w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.41 5.79 10 7.55 8.08 15 9.52 10.18 20 11.61 12.42 25 13.77 14.73 30 15.88 16.99 35 18.21 19.47 50 25.19 26.94
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.34499 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. …/126
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.274 & 275 -126- Shakun & Company (Services) Private Limited (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1963(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.275 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone Valerate-0.12%w/w 15gm 13.30 14.23” Gentamycin+ Gentamycin Sulphate 0.1%w/w Tube Quinidochlor (ICHQ) Quinidochlor (ICHQ)-3% w/w Cream/Ointmnts
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/127
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.275 -127- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.68 7.14 10 10.06 10.76 15 13.30 14.23 20 16.66 17.82 25 20.06 21.46 30 23.44 25.07 35 27.04 28.92 50 37.80 40.43
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.59699 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1964(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/128
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.276 -128- Shakun & Company (Services) Private Limited Shakun Sl.No.276 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20gm 16.50 17.65” Clioquinol (ICHQ) (as Valerate)-0.1%w/w Tube Cream/Ointments Clioquinol (ICHQ) - 3% w/w Chlorocresol 0.1% w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.64 7.10 10 10.00 10.70 15 13.18 14.10 20 16.50 17.65 25 19.88 21.26 30 23.22 24.84 35 26.76 28.62 50 37.42 40.02
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.58932 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/129
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.276 & 277 -129- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1965(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.277 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20gm 16.02 17.13” Neomycin (as Valerate)-0.12%w/w Laqured Tube Cream/Ointments Neomycin Sulphate - 0.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/130
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.277 -130- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.70 7.17 10 9.82 10.60 15 13.00 13.90 20 16.02 17.13 25 19.16 20.49 30 22.20 23.75 35 25.82 27.62 50 36.72 39.28
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.54632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1966(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/131
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.278 -131- Shakun & Company (Services) Private Limited Shakun Sl.No.278 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20gm 16.14 17.26” Miconazole Valerate-0.12%w/w Tube Cream/Ointments Miconazole Nitrate -2.0% w/w Chlorocresol 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.54 7.01 10 9.82 10.50 15 12.92 13.82 20 16.14 17.26 25 19.42 20.77 30 22.68 24.26 35 26.14 27.96 50 36.52 39.06
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.57132 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/132
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.278 & 279 -132- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1967(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.279 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20gm 16.32 17.46” Gentamycin + Valerate-0.12%w/w Tube Miconazole Nitrate Gentamycin Sulphate 0.10% w/w Cream/Ointments Miconazole Nitrate -2.0% w/w Chlorocresol 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/133
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.279 -133- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.60 7.06 10 9.90 10.59 15 13.06 13.97 20 16.32 17.46 25 19.66 21.02 30 22.94 24.54 35 26.46 28.29 50 36.96 39.53
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.58032 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1968(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/134
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.280 -134- Shakun & Company (Services) Private Limited Shakun Sl.No.280 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 756(E), dated 28th March, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone Betamethasone-4mg 1ml 3.82 4.08” Injections (as Sodium Phosphate) Vial/Ampoule
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 1 3.82 4.08 2 6.18 6.61 3 8.20 8.77 4 10.24 10.95 5 12.20 13.05 10 21.16 22.63 15 29.58 31.64 20 45.60 48.77 25 62.40 66.74
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 1.58000 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/135
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.280 & 281 -135- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1969(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.281 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 30gm 21.48 22.98” Cream/Ointments Valerate-0.1%w/w Tube Chlorocresol 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/136
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.281 -136- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.34 6.78 10 9.42 10.06 15 12.32 13.18 20 15.34 16.41 25 18.44 19.72 30 21.48 22.98 35 24.74 26.46 50 34.52 36.92
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.53165 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1970(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/137
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.282 -137- Shakun & Company (Services) Private Limited Shakun Sl.No.282 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 10gm 7.38 7.89” Neomycin + Valerate-0.05%w/w Tube Clotrimazole Neomycin - 0.5% w/w Cream/Ointments Clotrimazole - 1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.34 5.70 10 7.38 7.89 15 9.27 9.92 20 11.28 12.07 25 13.36 14.28 30 15.38 16.45 35 17.62 18.86 50 24.36 26.06
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.32832 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/138
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.282 & 283 -138- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1971(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.283 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1098(E), dated 30th April, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 10gm 7.90 8.45” Ketoconazole Dipropionate-0.064% w/w eq. to Tube Cream/Ointments Betamethasone -0.05% w/w Ketoconazole-2% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/139
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.283 -139- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.60 5.99 10 7.90 8.45 15 10.06 10.78 20 12.32 13.18 25 14.66 15.68 30 16.94 18.12 35 19.46 20.80 50 26.96 28.48
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.38032 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1972(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/140
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.284 -140- Shakun & Company (Services) Private Limited Shakun Sl.No.284 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2778(E), dated 27th November, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 15gm 8.34 8.92” Zinc Sulphate Dipropionate-0.064% w/w eq. to Tube Cream/Ointments Betamethasone -0.05% w/w Zinc Sulphate 2.5% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 5.02 5.37 10 6.76 7.23 15 8.34 8.92 20 10.04 10.74 25 11.80 12.62 30 13.52 14.46 35 15.46 16.54 50 21.26 22.74
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.26632 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/141
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.284 & 285 -141- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1973(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.285 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2348(E), dated 1st October, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 15gm 7.46 7.98” Neomycin Sulphate Dipropionate-0.025% w/w eq. to Tube Cream/Ointments Neomycin Sulphate - 0.050% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/142
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.285 -142- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 4.73 5.05 10 6.17 6.61 15 7.46 7.98 20 8.87 9.49 25 10.33 11.05 30 11.76 12.58 35 13.41 14.33 50 18.33 19.61
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.20765 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1974(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/143
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.286 -143- Shakun & Company (Services) Private Limited Shakun Sl.No.286 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 330(E), dated 23rd January, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 5gm 6.36 6.80” Neomycin Valerate - 0.12% w/w Tube Cream/Ointments Neomycin sulphate - 0.05%w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.36 6.80 10 9.44 10.10 15 12.36 13.22 20 15.40 16.47 25 18.50 19.79 30 21.56 23.06 35 24.84 26.57 50 34.66 37.07
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.53432 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/144
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.286 & 287 -144- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1975(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.287 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 723(E), dated 12th March, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 15gm 13.18 14.10” Clioquinole Valerate -0.12% w/w Tube Cream/Ointments Clioquinole (ICHQ) - 3% w/w Chlorocresol - 0.1% w/w
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/145
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.287 -145- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.64 7.10 10 9.98 10.67 15 13.18 14.10 20 16.50 17.65 25 19.86 21.24 30 23.20 24.81 35 26.76 28.62 50 37.40 40.00
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.58899 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1976(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/146
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.288 -146- Shakun & Company (Services) Private Limited Shakun Sl.No.288 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each gm contains “1. Betamethasone+ Betamethasone 20gm 15.84 16.94” Salicylic Acid Valerate-0.12%w/w Laqured Cream/Ointments Salicylic Acid 3.0% w/w Tube
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in gm. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 6.66 7.12 10 9.74 10.42 15 12.86 13.78 20 15.84 16.94 25 18.94 20.26 30 21.94 23.46 35 25.50 27.29 50 36.28 38.79
For pack size other than pack size given in column (1) of the table-II deduct @ Rs 0.53732 per gm. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.12 per gm. shall be deducted from price so worked out for pack size between 36 to 50 gm. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/147
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.288 & 289 -147- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1977(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.289 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone+ Betamethasone 20ml 9.14 9.78” Gentamycin Dipropionate-0.064% w/v eq. to Bottle Lotion/Solutions Betamethasone -0.05% w/v Gentamycin (as Sulphate) - 0.1% w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/148
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.289 -148- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 6.86 7.34 20 9.14 9.78 30 12.48 13.35 50 18.02 19.27 100 32.36 34.61 150 47.22 50.51 200 60.86 65.10 250 74.80 80.01 500 144.88 154.96
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26632 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1978(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/149
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.290 -149- Shakun & Company (Services) Private Limited Shakun Sl.No.290 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1323(E), dated 5th June, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone+ Betamethasone 50ml 17.78 19.02” Zinc Sulphate + Dipropionate eq. to Bottle Methyl Paraben + Betamethasone -0.05% w/v Propyl Paraben Zinc Sulphate-0.5%w/v Lotion/Solutions Methyl Paraben-0.18%w/v Propyl Paraben - 0.02%w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 6.82 7.29 20 9.56 10.23 30 12.34 13.20 50 17.78 19.02 100 31.88 34.10 150 46.50 49.74 200 59.90 64.07 250 73.60 78.72 500 142.48 152.40
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26152 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. …/150
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.290 & 291 -150- Shakun & Company (Services) Private Limited (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1979(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.291 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2047(E), dated 30th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size
Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone+ Betamethasone 20ml 9.62 10.29” Salicylic Acid Dipropionate eq. to Bottle Lotion/Solutions Betamethasone -0.05% w/v Salicylic Acid- 3.0%w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/151
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.291 -151- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 6.86 7.34 20 9.62 10.29 30 12.46 13.33 50 17.96 19.21 100 32.26 34.51 150 47.08 50.36 200 60.66 64.88 250 74.56 79.75 500 144.38 154.43
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26532 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1980(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/152
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.292 -152- Shakun & Company (Services) Private Limited Shakun Sl.No.292 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2057(E), dated 30th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone+ Betamethasone -0.05% w/v 16ml 8.64 9.24” Clotrimaxole Clotrimaxole 1%w/v Container/ Lotion/Solutions Tube
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 6.90 7.38 20 9.72 10.40 30 12.58 13.46 50 18.18 19.45 100 32.68 34.95 150 47.72 51.04 200 61.52 65.80 250 75.62 80.88 500 146.50 156.70
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26957 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/153
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.292 & 293 -153- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1981(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.293 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 226(E), dated 14th February, 2007 and S.O. 2768(E), dated 27th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone+ Betamethasone 25ml 11.10 11.87” Salicylic Acid Dipropionate-0.064% w/v eq. to Bottle Lotion/Solutions Betamethasone -0.05% w/v Salicylic Acid - 2% w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/154
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.293 -154- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 6.84 7.32 20 9.60 10.27 30 12.42 13.38 50 17.90 19.15 100 32.12 34.36 150 46.86 50.12 200 60.38 64.58 250 74.20 79.36 500 143.68 153.68
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26932 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1982(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/155
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.294 -155- Shakun & Company (Services) Private Limited Shakun Sl.No.294 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 441(E), dated 23rd March, 2007 and S.O. 2768(E), dated 27th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone Betamethasone 25ml 10.98 11.74” Lotion/Solutions Dipropionate 0.064% w/v eq to Bottle Betamethasone 0.05% w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 6.80 7.27 20 9.50 10.16 30 12.28 13.13 50 17.66 18.89 100 31.64 33.84 150 46.14 49.35 200 59.42 63.56 250 73.00 78.08 500 141.28 151.11
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.25912 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs. 0.06 per 5 ml. shall be deducted from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/156
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.294 & 295 -156- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1983(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.295 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2047(E), dated 30th November, 2007, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone + Betamethasone - 0.5 mg 15ml 10.14 10.85” Methyl Hydroxy (as sodium phosphate) Bottle with Benzoate+Propyl Methyl Hydroxy Dropper & Hydroxy Benzoate Benzoate- 0.06%w/v Carton Drops Propyl Hydroxy Benzoate- 0.03%w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/157
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.295 -157- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 7.34 7.85 10 8.68 9.28 15 10.14 10.85 20 11.50 12.30 30 14.36 15.36 50 20.24 21.65 100 34.98 37.41
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26859 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1984(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/158
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.296 -158- Shakun & Company (Services) Private Limited Shakun Sl.No.296 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone + Betamethasone Sodium 5ml vial 9.56 10.23” Gentamycin Phosphate 0.1% w/v with Dropper Eye/Ear Drops Gentamycin Sulphate eq to & Carton 0.3% w/v of Gentamycin Base
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 9.56 10.23 10 12.94 13.84 15 15.60 16.69 20 18.88 20.19 30 23.80 25.46 50 34.52 36.92 100 60.92 65.16
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.41200 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/159
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.296 & 297 -159- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1985(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.297 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 1963(E), dated 9th August, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone + Betamethasone Sodium 10ml 15.04 16.09” Benzyl Alcohol Phosphate eq to Vial Injections Betamethasone - 2mg Benzyl Alcohol 4%w/v Chlorocresol- 0.1%w/w (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/160
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.297 -160- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 10.32 11.04 10 15.04 16.09 15 19.04 20.37 20 23.72 25.37 30 31.76 33.97 50 48.70 52.09 100 90.50 96.80
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.76000 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1986(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/161
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.298 -161- Shakun & Company (Services) Private Limited Shakun Sl.No.298 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 76(E), dated 15th January, 2004, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone Betamethasone - 0.5 mg 10ml 8.68 9.28” Drops (as sodium phosphate) Bottle with Dropper & Carton
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 7.34 7.85 10 8.68 9.28 15 10.14 10.85 20 11.48 12.28 30 14.34 15.34 50 20.20 21.61 100 34.92 37.35
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.26792 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
…/162
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.298 & 299 -162- Shakun & Company (Services) Private Limited (g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1987(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.299 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2768(E), dated 27th November, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone + Betamethasone 5 vial 8.14 8.71” Gentamycin + Dipropionate-0.025% w/v with Dropper Clotrimazole + Gentamycin Sulphate eq. & Carton Lignocaine Gentamycin -0.3% w/v Eye/Ear Drops Clotrimazole 1% w/v Lignocaine HCL-2.0%w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/163
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.299 -163- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 8.14 8.71 10 10.10 10.80 15 11.34 12.13 20 13.20 14.12 30 15.28 16.34 50 20.32 21.73 100 32.52 34.78
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.12800 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1988(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/164
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.300 -164- Shakun & Company (Services) Private Limited Shakun Sl.No.300 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 2768(E), dated 27th November, 2008, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone + Betamethasone 5 ml vial 7.24 7.74” Gentamycin + Dipropionate-0.025% w/v with Dropper Clotrimazole + Gentamycin Sulphate eq. Lignocaine Gentamycin -0.3% w/w Eye/Ear Drops Clotrimazole 1% w/w Lignocaine HCL-2.0%w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 7.24 7.74 10 9.20 9.84 15 10.44 11.17 20 12.30 13.16 30 14.38 15.38 50 19.12 20.45 100 31.02 33.18
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.12800 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/ marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/forms claimed,
the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/165
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.300 & 301 -165- Shakun & Company (Services) Private Limited (f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1989(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.301 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 168(E), dated 29th January, 2009, in so far as it relates to formulation packs mentioned in the table-I below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table-I below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table-I below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table-I with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table-I : Ceiling Price and Equivalent MRP for Specified Pack Size
Sl. No.
Name of the formulation
Strength Pack Size Ceiling Price (Rs.)
Equivalent MRP* (inclusive of all
taxes) (Rs.) (1) (2) (3) (4) (5) (6)
Each ml contains “1. Betamethasone + Betamethasone Sod. 5 ml 7.40 7.92” Gentamycin + Phosh-0.1% w/v Plastic Bottle Benzaolkonium Gentamycin Sulphate eq. Chloride Drops Gentamycin -0.3% w/v Benzaolkonium Chloride Solution - 0.02% w/v
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:- …/166
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.301 -166- Shakun & Company (Services) Private Limited
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 5 7.40 7.92 10 9.42 10.08 15 11.92 12.75 20 13.94 14.91 30 17.96 19.21 50 26.54 28.39 100 48.34 51.70
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.40192 per ml. from the ceiling price mentioned in column (2) of the nearest higher pack size. These prices shall be worked out by manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices (inclusive of excise duty, sales tax/VAT and local taxes if any) in
column (6) of table-I, for the specified pack and packs of similar strength, and manufacturer/ marketing company cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The manufacturer/marketing company may add taxes only if they have actually paid to the Government on the
price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in Form-V of DPCO, 1995.
(d) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated
27.1.1998 for tablet(s) and capsule(s) packed in strip/blister. (e) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the ceiling prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by
the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the Competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(h) The ceiling price arrived on the basis of above shall not exceed the MRP by multiplying the ceiling price by a factor
of 1.0696 as per the existing rates of excise duty and VAT. (i) The MRP arrived as above shall be subject to payment of Government levies/taxes as applicable and necessary
adjustment in the factor of 1.0696 shall necessarily be required to be made by the manufacturer/marketing company, whenever the existing rate of excise duty and/or VAT undergoes a change, subject to the condition that the excise duty and/or VAT so calculated shall in no case exceed the actual excise duty and/or VAT paid by the manufacturer/marketing company or as applicable as per the factor of 1.0696. The manufacturer/marketing company shall be specifically liable to ensure the compliance of this condition.
(j) Any other formulation/composition not covered in the above table that has any one of the scheduled drugs in
Column No. (3) as one of its ingredients, it shall be subject to the price ceiling at respective serial number of the table, as the case may be, unless the manufacturer has got hereafter specific price fixed by the NPPA for that formulation.
(k) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
(l) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the price order(s) issued
prior to this date of notification stand withdrawn.
Sd/- (Manish Goswami) Deputy Director
S.O.1990(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/167
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.302 -167- Shakun & Company (Services) Private Limited Shakun Sl.No.302 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Pfizer Products India Pvt. Ltd.
TABLE
Sl. No.
Name of the formulation Pack Size Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes
(Rs.) (1) (2) (3) (4) (5) (6)
1.
Medrol Tablets Methyl Prednisolone - 4 mg Batch No. K498A & K654A/ Qty. 61588 Strips
Each tablet contains 10x10’s
Strip/Blister
332.75
332.75
346.06
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1991(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/168
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.303 -168- Shakun & Company (Services) Private Limited Shakun Sl.No.303 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s Win-Medicare Pvt. Ltd..
TABLE
Sl. No.
Name of the formulation Pack Size
Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales
Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes (Rs.)
(1) (2) (3) (4) (5) (6) Each gm contains 1. Daivobet Ointment
Calcipotriol(as Hydrate) 50mcg Betamethasone Dipropionate 0.5mg Batch no. EC 7629/Qty. 12000 tubes
15 gm Tube
802.36 782.26 813.55”
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1992(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/169
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.304 -169- Shakun & Company (Services) Private Limited Shakun Sl.No.304 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/ imported by M/s. Aventis Pharma Ltd.
TABLE
Sl. No.
Name of the formulation Pack Size
Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/
VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes (Rs.)
(1) (2) (3) (4) (5) (6) Each ml contians “1. Lantus 100 IU/ML Cartridge 3ml 543.12 488.98 508.54 Monocomponent Insulin Cartridge Glargine - 100 IU Batch No. 40U 577 2. Lantus 100 IU/ML Solostar 3ml 855.60 770.21 801.02 Each ml contians Cartridge Monocomponent Insulin Glargine - 100 IU Batch No. 40U148 3. Apidra U 100 Solostar 3ml 620.05 558.22 580.55 Each ml contains Pen Containing Monocomponent Insulin Cartridge & Needles Glargine 100 IU B.No. 40U149 4. Lantus 100 IU/ml Optiset 3ml Vial 734.34 661.08 687.52” Optiset of vial and needles Optiset with Each Vial contains Syringe and Needles Monocompoent Insulin Glargine-100 IU/ml Batch No. 40U3000
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
…/170
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.304 & 305 -170- Shakun & Company (Services) Private Limited
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1993(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.305 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Novo Nordisk India Pvt. Ltd.
TABLE
Sl. No.
Name of the formulation Pack Size
Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes
(Rs.) (1) (2) (3) (4) (5) (6)
“1. Levemir Flex Pen 5x3 ml 5088.17 4580.24 4763.45 Each ml contains Cartridge with Insulin Detemir solution Flex Pen for injection, (Monocomponent Biosynthetic Recombinant DNA origin) 100 IU/ml in 3 ml precision delivery device Batch no. XP51094 2. Novo Rapid Flex Pen 5x3 ml 2986.55 2688.79 2796.34 Each ml contains Cartridge with Soluble Insulin Aspart (Monocomponent, Flex Pen Biosynthetic Recombinant DNA origin) 100 U/ml in 3 ml precision delivery Batch no. XP50740 3. Novo Mix 30 Flex Pen 5x3 ml 2986.55 2688.79 2796.34 Each ml contains Flex Pen Mixture of soluble Insulin Aspart and Protamin Crystallised Insulin Aspart (Monocomponent Biosynthetic Recombinant DNA origin) in 100 IU/ml in 3 ml precision delivery device Batch no. XP50977 4. Levemir Penfill 5x3ml Cartridge 2495.15 2246.53 2336.39” Each Cartridge contains along with Penfill Recombinant Human Insulin Precision 100IU/3ml Cartridge Delivery Device Batch No. VS60370
*Subject to actual payment of Government levies/taxes, as applicable.
…/171
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.305 & 306 -171- Shakun & Company (Services) Private Limited Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1994(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.306 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Eli-Lilly & Co.(I) Pvt. Ltd.
TABLE
Sl. No.
Name of the formulation Pack Size
Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes (Rs.)
(1) (2) (3) (4) (5) (6) “1. Monocomponent Insulin 3ml 397.12 357.59 371.89” Humalog Mix 50 100IU/ml Cartridge Each ml contain: 50% Insulin Lispro and 50% Insulin Lispro Protamine Suspension, r-DNA Origin Batch No. A564492A 2. Monocomponent Insulin 3ml 397.12 357.59 371.89 Humalog 100 IU/ml Cartridge Each ml contain: Insulin Lispro 100IU Batch No. A564483C
…/172
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.306 -172- Shakun & Company (Services) Private Limited
(1) (2) (3) (4) (5) (6) 3. Monocomponent Insulin 3ml 397.75 357.59 371.89 Humalog Mix 25 100 IU/ml Cartridge Each ml contain: 25% Insulin Lispro and 75% Insulin Lispro Protamine suspension, r-DNA origin Batch No. A574875E 4. Monocomponent Insulin 3ml 522.73 470.64 489.47 Humalog Pen 100 IU/ml Disposable (Insulin Lispro) Pen Each ml contain: 100 IU Insulin Lispro Ph. Eur. (r-DNA origin) B. No. A569839D 5. Monocomponent Insulin 3ml 522.73 470.64 489.47 Humalog Mix 50 Pen 100IU/ml Disposable Each ml contain: Pen 50% Insulin Lispro and 50% Insulin Lispro Protamine Suspension, r-DNA Origin B. No. A560780E 6. Monocomponent Insulin 3ml 523.53 470.64 489.47” Humalog Mix 25 Pen 100IU/ml Disposable Each ml contain: Pen 25% Insulin Lispro and 75% Insulin Lispro Protamine suspension, r-DNA origin, Batch No. A558653D
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1995(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/173
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.307 -173- Shakun & Company (Services) Private Limited Shakun Sl.No.307 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and Paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Biocon Ltd.
TABLE
Sl. No.
Name of the formulation Pack Size
Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes
(Rs.) (1) (2) (3) (4) (5) (6)
“1. Basalog 3ml -- 130.04 135.24 Insulin Glargine Injection Cartridge Each ml contains Insulin Glargine (r DNA Orgin) 100IU Benzyl Alcohol 1% w/v (as preservative) 2. Basalog 3ml -- 222.18 231.07” Insulin Glargine Injection Cartridge Each ml contains with pen Insulin Glargine (r DNA Orgin) 100IU Benzyl Alcohol 1% w/v (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1996(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/174
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.308 -174- Shakun & Company (Services) Private Limited Shakun Sl.No.308 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and Paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Wockhardt.
TABLE
Sl. No.
Name of the formulation Pack Size
Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes (Rs.)
(1) (2) (3) (4) (5) (6) 1. Glaritus 3ml -- 130.04 135.24 Recombinant Insulin Cartridge Glargine Injection Each ml contains Insulin Glargine 100IU m-cresol USP 0.27% w/v (as preservative) 2. Glaritus 3ml -- 222.18 231.07 Recombinant Insulin Cartridge Glargine Injection with Pen Each ml contains Insulin Glargine 100IU m-cresol USP 0.27% w/v (as preservative)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/ NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1997(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II
…/175
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.309 -175- Shakun & Company (Services) Private Limited Shakun Sl.No.309 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. RPG Life Sciences Limited
TABLE
Sl. No.
Name of the formulation Pack Size Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes (Rs.)
(1) (2) (3) (4) (5) (6) “1. Spirolactone tablet 10’s 14.92 16.10 17.22 Each tablet contains Strip/Blister Spironolactone - 25mg (Aldactone 25mg tablet) 2. Spirolactone tablet 10’s 29.16 31.52 33.71 Each tablet contains Strip/Blister Spironolactone - 50mg (Aldactone 50mg tablet) 3. Spirolactone tablet 10’s 57.44 62.08 66.40 Each tablet contains Strip/Blister Spironolactone - 100mg (Aldactone 100mg tablet) 4. Spirolactone + Frusemide tablet 10’s 29.94 32.26 34.51” Each film coated tablet contains Strip/Blister Spironolactone - 50mg Frusemide - 20mg (Spiromide - 50mg tablet)
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The company is required to submit the quarterly return indicating the quantity of captive consumption and sales
of Spironolactone bulk drug by the 10th of subsequent month of preceding quarter duly certified by the Chartered Accountant/Cost Accountant and authorized signatory of the company.
(b) The ceiling price order No. S.O. 1332(E) dated 01.08.2007 will not be applicable in this case. (c) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(d) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(e) For different packing material used or, different drug delivery systems or any other special features/forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
…/176
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.309 & 310 -176- Shakun & Company (Services) Private Limited (g) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(h) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(i) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.1998(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.310 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/ imported by M/s. Nicholas Piramal India Ltd., Gujarat
TABLE
Sl. No.
Name of the formulation Pack Size Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes (Rs.)
(1) (2) (3) (4) (5) (6) “1. Erythrotone 250 Tablet 10’s -- 18.14 20.08” Each tablet contains Strip/Blister Erythromycin Estolate eq. to Erythromycin-250mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies approaches NPPA for specific price approvals for its formulations.
…/177
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.310 & 311 -177- Shakun & Company (Services) Private Limited (d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(g) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/-
(Manish Goswami) Deputy Director
S.O.1999(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Shakun Sl.No.311 -COPY OF- ORDER Dated 3rd August, 2009
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table-I hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table-I with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Quixotic Healthcare, HP/Tridoss Lab Ltd., Mumbai
TABLE
Sl. No.
Name of the formulation Pack Size Existing Retail Price
(Rs.)
Retail Price without Excise Duty Sales Tax/ VAT and Local Tax, if any (Rs.)
Equivalent MRP*
inclusive of all taxes
(Rs.) (1) (2) (3) (4) (5) (6)
“1. Erywok Suspension 60ml Bottle -- 22.24 24.62” Each 5ml contains with M. Cup Erythromycin Estolate eq. to Erythromycin-125mg
*Subject to actual payment of Government levies/taxes, as applicable. Note : (a) In addition to packs specified in column (4) of the strength notified in column (3) of the table-I, the following
ceiling prices are fixed:-
Table-II: Ceiling Prices and Equivalent MRP of other Pack Size
…/178
Volume in ml. Ceiling Price in Rs. Equivalent MRP* (inclusive of all taxes) (Rs.)
Column (1) Column (2) Column (3) 10 8.32 8.90 20 11.26 12.04 30 13.68 14.63 50 19.08 20.41 100 32.88 35.17 150 46.86 50.12 200 59.46 63.60 250 72.16 77.18 500 136.76 146.28
Information on this page is provided by Shakun & Company (Services) Private Limited, New Delhi, India to its subscribers against the annual subscription. Non-subscribers may visit www.shakun.com for more details.
Shakun Sl.No.311 -178- Shakun & Company (Services) Private Limited
For pack size other than pack size given in column (1) of the table-II deduct @ Rs. 0.24253 per ml. from the
ceiling price mentioned in column (2) of the nearest higher pack size, further, Rs.0.06 per 5 ml. shall be deducted
from price so worked out for pack size between 251 to 500 ml. These prices shall be worked out by
manufacturer/marketing company and the price so worked out shall be adopted as ceiling price corresponding to
price notified in column (5) and equivalent MRP notified in column (6) of the table-I.
(b) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local
taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any
ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(c) The companies/manufacturers may added taxes only if they have paid actually to the Government on the price
mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be
intimated to the NPPA in the Form-V of DPCO, 1995.
(d) For different packing material used or, different drug delivery systems or any other special features/ forms
claimed, the retail prices, as specified in Column No. 5 above, shall be applicable unless the companies
approaches NPPA for specific price approvals for its formulations.
(e) The manufacturer and marketing company for the above said formulation shall be required to take the requisite
prior approval from the competent Authority for any change in the composition of the above said formulation with
written prior intimation to the National Pharmaceutical Pricing Authority.
(f) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub
para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of
paragraph 14 of the Drugs (Prices Control) Order, 1995.
(g) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented
by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such
formulation pack under the Drugs and Cosmetics Act, 1940.
(h) The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes
hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount
along with the interest under the provisions of the DPCO, 1995 read with the EC Act, 1955.
Sd/- (Manish Goswami) Deputy Director
S.O.2000(E) PN/110/2009/F F.No.8(19)/2009/D.P./NPPA-Div.-II Issued by: Ministry of Chemicals and Fertilizers National Pharmaceutical Pricing Authority New Delhi
** ** **